5SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549-1004

FORM 8-K

CURRENT REPORT


Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

December 15, 1999
Date of Report (Date of earliest event reported)

BIOMET, INC.
(Exact name of registrant as specified in its charter)

Indiana               0-12515                           35-1418342
(State or other       (Commission File Number)          (IRS Employer
jurisdiction of                                         Identification Number)
incorporation)


Airport Industrial Park                                 46581-0587
P.O. Box 587                                            (Zip Code)
Warsaw, Indiana
(Address of principal executive offices)



Registrant's telephone number, including area code (219) 267-6639






Item 2.  Acquisition or Disposition of Assets

         On December 15, 1999, Biomet, Inc.  ("Biomet")  completed the merger of
         Implant Innovations International Corporation ("Implant") with and into
         Palm  Acquisition  Corp.,  a  wholly-owned  subsidiary of Biomet.  Upon
         completion of the merger,  Palm Acquisition  Corp.  changed its name to
         Implant  Innovations  Holding  Corporation.  In  connection  with  this
         merger, Biomet issued approximately 5.2 million Biomet common shares to
         the individuals  and entities  holding shares of Implant on the closing
         date.   This  merger  was  accounted  for  as  a   pooling-of-interests
         transaction.  Under this method of accounting,  the recorded historical
         cost basis of the assets and  liabilities of Biomet and Implant for the
         entire  fiscal  period  in  which  the  combination  occurred,  and the
         historical  results of operations of the separate  companies for fiscal
         years prior to the merger,  are combined and reported as the results of
         operations of the combined company.  If the merger fails to qualify for
         pooling-of-interests  accounting  treatment,  the  purchase  method  of
         accounting will be applied.

         Through its  subsidiaries,  Implant  designs,  develops,  manufactures,
         markets  and  distributes  oral  reconstruction  products  including  a
         proprietary  line of dental  implants,  healing  abutments and surgical
         products along with regenerative membrane products manufactured by W.L.
         Gore and  Associates,  Inc.  and  synthetic  bone  substitute  material
         manufactured by Orthovita, Inc.

         Implant  markets its products to dental  professionals  involved in the
         implant    procedure,    including   oral   surgeons,    periodontists,
         implantologists,  general dentists and prosthodontists. Implant markets
         and distributes its products through a direct sales force in the United
         States,  Germany,  Canada,  the  United  Kingdom,  Spain,  Switzerland,
         Denmark and  Mexico.  It markets  its  products in other  international
         markets  through  its  exclusive  independent  distributors.  Implant's
         manufacturing   facilities   are  in  Palm  Beach   Gardens,   Florida.
         Subsidiaries  of Implant  have sales  offices in Germany,  Canada,  the
         United Kingdom, Spain, Switzerland, Denmark and Mexico.

Item 7.    Financial Statements and Exhibits

         (a)      Financial statements of businesses acquired

                  Not applicable

         (b)      Pro forma financial information

                  Not applicable






(c)      Exhibits

          2.01 Agreement and Plan of Merger, dated August 28, 1999, by and among
               Biomet,   Inc.,  Palm  Acquisition  Corp.,   Implant  Innovations
               International  Corporation,  Implant Innovations,  Inc. and those
               shareholders  of Implant  Innovations  International  Corporation
               whose  names  appear  on the  signature  pages of the  Agreement.
               (Incorporated  by reference to Exhibit 2.1 to Biomet,  Inc.  Form
               S-4 Registration Statement, File Number 333-88905).




SIGNATURE

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                       BIOMET, INC.



                                       By:  /s/ Daniel P. Hann
                                          --------------------------------------
                                           Daniel P. Hann, Senior Vice President


Dated: December 29, 1999





EXHIBIT INDEX


Number Assigned
In Regulation
S-K Item 601                        Description of Exhibit
- ---------------                     ----------------------

      (2)       2.01     Agreement and Plan of Merger, dated August 28, 1999, by
                         and among Biomet, Inc., Palm Acquisition Corp., Implant
                         Innovations    International    Corporation,    Implant
                         Innovations,  Inc.  and those  shareholders  of Implant
                         Innovations   International   Corporation  whose  names
                         appear  on  the  signature   pages  of  the  Agreement.
                         (Incorporated  by  reference  to Exhibit 2.1 to Biomet,
                         Inc.  Form  S-4  Registration  Statement,  File  Number
                         333-88905).